Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · Real-Time Price · USD

4.630

-0.050 (-1.07%)

At close: Mar 17, 2026, 4:00 PM EDT

4.680

+0.050 (1.08%)

After-hours: Mar 17, 2026, 7:55 PM EDT

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	21.06	8.71	16.9	22.64	45.04	39.98
Cash & Short-Term Investments	21.06	8.71	16.9	22.64	45.04	39.98
Cash Growth	171.65%	-48.45%	-25.32%	-49.75%	12.67%	221.17%
Other Receivables	-	-	-	2.5	3.66	2.37
Total Trade Receivables	-	-	-	2.5	3.66	2.37
Other Current Assets	1.59	1.95	2.16	2.32	3.86	4.92
Total Current Assets	22.65	10.66	19.07	27.45	52.57	47.26
Net Property, Plant & Equipment	4.35	4.93	5.78	6.77	3.96	5.54
Other Long-Term Assets	-	-	-	-	0.07	0.75
Total Assets	27	15.59	24.84	34.22	56.6	53.55
Accounts Payable	2.22	3.05	3.98	3.5	3.46	5.58
Accrued Expenses	1.9	1.86	2.1	2.11	2.08	2.76
Current Portion of Long-Term Debt	-	-	-	2	11.67	5
Other Current Liabilities	1.49	1.3	1.14	1.1	17.55	1.2
Total Current Liabilities	5.61	6.21	7.22	8.71	34.76	14.54
Long-Term Debt	-	-	-	1.46	3.71	20.05
Long-Term Leases	3.99	4.63	5.4	6.08	1.34	2.36
Other Long-Term Liabilities	-	-	-	-	15.58	-
Total Long-Term Liabilities	3.99	4.63	5.4	7.54	20.63	22.41
Total Liabilities	9.6	10.84	12.62	16.24	55.39	36.95
Common Stock	0.11	0.08	0.06	0.05	0.05	0.05
Additional Paid-in Capital	286.5	252.25	235.61	223.96	215.23	202.15
Retained Earnings	-269.22	-247.58	-223.45	-206.04	-214.06	-185.61
Shareholders' Equity	17.39	4.76	12.22	17.97	1.22	16.59
Total Liabilities & Equity	27	15.59	24.84	34.22	56.6	53.55
Total Debt	3.99	4.63	5.4	9.54	16.72	27.41
Net Cash (Debt)	17.07	4.09	11.51	13.1	28.33	12.57
Net Cash Growth	317.89%	-64.50%	-12.16%	-53.76%	125.46%	-
Net Cash Per Share	10.37	5.33	575.35	1504561.51	3541644.69	2171710.74
Book Value	17.39	4.76	12.22	17.97	1.22	16.59
Book Value Per Share	10.56	6.20	611.05	2064350.28	152022.31	2868075.45
Tangible Book Value	17.39	4.76	12.22	17.97	1.22	16.59
Tangible Book Value Per Share	10.56	6.20	611.05	2064350.28	152022.31	2868075.45

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q